에임드바이오
20,550KRWMarket close of 10/27 (Tue)
Down -5.73%-1,250KRWMarket close of 10/27 (Tue)
Preliminary value — replaced once official KRX data for the same date is publishedClose of 10/28 (Wed)20,850KRWUp +1.46%
Preliminary · replaced once official KRX data for the same date is published
- Open
- 22,250
- High
- 22,800
- Low
- 20,450
- Day range
- Day range low 20,450 high 22,800, open 22,250, close 20,550, previous close 21,800
- Volume
- 22×10K shares
- 4.8B KRW 1.59× the 20-session average
Market close of 10/27 (Tue)
Where it sits in the 1-year range
5%5% of the way up from the lowest close in 1 year (216 sessions) · -71.7% from the high
Free · no sign-inSource from 2021-05-17
Points to check
- Earningsnot verifiedThe last four quarters are incomplete, so not verified
- Recent filingsnot verifiedOutside filing data coverage, so not verified
- Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
The other 2 are within the usual range
- Daily move-5.73%usual range
- Trading value1.6×usual range
See the full check report
Quarterly results · Q1 2026
- Revenue8.5B KRW
- vs. year ago
- —
- vs. prior quarter
- —
- Operating income-4.0B KRW
- vs. year ago
- —
- vs. prior quarter
- —
- Operating margin-46.6%
- vs. year ago
- —
- vs. prior quarter
- —
Quarterly operating income trend
As of the latest official close · 2026-10-27Valuation filing date · 2026-05-15Same sector · 바이오 R&D
Down -0.67%· 26 of 64 stocks up, preferred shares excluded · trading value 190.2B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 알테오젠 | Close over the last 20 sessions -12.6% | Flat 0.00% | 51.8B KRW |
| 올릭스 | Close over the last 20 sessions -11.8% | Down -5.72% | 24.1B KRW |
| 디앤디파마텍 | Close over the last 20 sessions -8.3% | Up +0.37% | 14.0B KRW |
| 리가켐바이오 | Close over the last 20 sessions -20.9% | Down -1.54% | 12.1B KRW |
| 페니트리움바이오 | Close over the last 20 sessions -4.2% | Up +14.41% | 9.8B KRW |
Schedule
- Next data 10/29 (Thu) after 08:50
Related news
Tables, financials, investor flows and filing history are in the Detailed view.
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 82% of trading value, about 92% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.